Accuray Launches Stellar™ Solution to Revolutionize Adaptive Radiotherapy for Cancer Treatment

Accuray Unveils Accuray Stellar™ Solution to Transform Adaptive Radiotherapy

Accuray Incorporated announces the launch of its groundbreaking Accuray Stellar™ Solution, poised to revolutionize adaptive radiotherapy for cancer patients. Set to be unveiled at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting in San Francisco, this innovative solution is designed to provide clinical teams with a comprehensive suite of tools that enhance the delivery of personalized radiotherapy. The Accuray Stellar Solution, which integrates the Radixact® Treatment Delivery System, offers a streamlined approach to implementing adaptive radiotherapy techniques, ensuring that patients receive tailored treatments throughout their cancer journey.

With the Accuray Stellar Solution, the company aims to improve patient outcomes by providing precise treatment options that can enhance tumor control and overall survival rates. Suzanne Winter, Accuray's president and CEO, emphasizes the importance of this technology in delivering effective cancer care. The system supports a variety of radiation delivery methods, including image-guided radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and surface-guided radiation therapy (SGRT), addressing a wide range of cancer types such as breast, prostate, lung, and head and neck cancers. Furthermore, the system is equipped to handle complex cases, including total marrow irradiation, thereby expanding its applicability in the oncology field.

A critical feature of the Accuray Stellar Solution is its real-time motion tracking and correction capabilities, which adapt to changes in tumor size or shape during treatment. This advancement not only broadens the reach of transformative cancer care but also integrates seamlessly with Accuray’s proprietary software and hardware, as well as third-party technologies. By simplifying the treatment workflow, the Accuray Stellar Solution optimizes outcomes for patients, reflecting the company's dedication to innovation with purpose and compassion in personalized radiotherapy.

In addition to the launch of the Accuray Stellar Solution, Accuray continues to focus on enhancing its technological offerings and fostering collaborations within the healthcare community. By prioritizing the needs of patients and healthcare providers, the company seeks to maintain its leadership in the evolving landscape of cancer treatment.

As the ASTRO Annual Meeting approaches, Accuray's commitment to advancing adaptive radiotherapy signals a significant step forward in the fight against cancer, promising enhanced treatment options for diverse patient populations.